Cationically modified inhalable nintedanib niosomes: enhancing therapeutic activity against non-small-cell lung cancer.
Sign Up to like & getrecommendations! Published in 2022 at "Nanomedicine"
DOI: 10.2217/nnm-2022-0045
Abstract: Aim: This study was designed to develop and test nintedanib-loaded niosomes as inhalable carriers for enhancing its therapeutic efficacy via localized drug accumulation and addressing issues such as low bioavailability and severe toxicity. Methods: Niosomes… read more here.
Keywords: lung cancer; cationically modified; lung; enhancing therapeutic ... See more keywords